logo

For the Inventor, By the Inventor

Copenhagen, Denmark

Per Sauerberg

This inventor holds 1 USPTO granted patent. Top assignee: H. Lundbeck A/s. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Per Sauerberg. Retrieved from https://idiyas.com/inventor/per-sauerberg-7beqe7sq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal1 out of 513 
 
H. Lundbeck A/s
 patents

Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents
1. 4608378 - Tetrahydroisoxazolo[4,5-c]pyridine derivatives useful in the treatment (1986-08-26),

Title: Per Sauerberg: Innovator in Pharmaceutical Chemistry

Introduction

Per Sauerberg is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical treatments. His work focuses on addressing disorders related to the acetylcholine and muscarinic systems.

Latest Patents

Sauerberg holds a patent for "Tetrahydroisoxazolo[4,5-c]pyridine derivatives useful in the treatment." This invention relates to novel compounds that can be utilized in pharmaceutical compositions. The compounds are designed to treat disorders caused by the malfunction of the acetylcholine or muscarinic system. The patent includes individual isomers and pharmaceutically acceptable acid addition salts, with specific structural formulas detailing the variations of the compounds.

Career Highlights

Per Sauerberg is associated with H. Lundbeck A/S, a prominent company in the pharmaceutical industry. His work at Lundbeck has allowed him to focus on innovative solutions for complex medical issues. With a patent count of 1 patent, he continues to contribute to advancements in drug development.

Collaborations

Sauerberg has collaborated with esteemed colleagues such as Erik Falch and Povl Krogsgaard-Larsen. These partnerships have fostered a collaborative environment that enhances research and innovation in the pharmaceutical sector.

Conclusion

Per Sauerberg's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His patented work on tetrahydroisoxazolo derivatives showcases his commitment to improving treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…